<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6249340\results\search\disease\results.xml">
  <result pre="IAV can result in severe or fatal clinical complications including" exact="pneumonia" post="and respiratory distress syndrome. Treatment of IAV infections is"/>
  <result pre="ANXs as a suitable target for IAV therapy. annexins ANXA1" exact="influenza" post="virus FPR2 immunomodulatory Funding National Medical Research Council10.13039/501100001349NMRC/CBRG/0056/2014 fig-count:"/>
  <result pre="2018). An estimate of 3–5 million individuals suffer from severe" exact="influenza" post="infection annually (WHO, 2018), with 290,000–650,000 resulting in deaths"/>
  <result pre="et al., 2011; WHO, 2018). Among the four types of" exact="influenza" post="viruses (types A, B, C, and D), Influenza A"/>
  <result pre="IAV-related complications such as bronchitis, sinus infections, ear infections, and" exact="pneumonia" post="may arise, which can result in organ failure and"/>
  <result pre="failure and death (CDC, 2018). The recurrence of such seasonal" exact="influenza" post="epidemics is primarily due to the constant mutation of"/>
  <result pre="a large host-range, there is a continuous emergence of new" exact="influenza" post="viruses that results in periodic pandemics (Taubenberger and Morens,"/>
  <result pre="At present, there are two fundamental approaches to managing the" exact="influenza" post="epidemic: vaccination and, treatment using antivirals. Several influenza vaccines"/>
  <result pre="managing the influenza epidemic: vaccination and, treatment using antivirals. Several" exact="influenza" post="vaccines are available with several modes of administration such"/>
  <result pre="2011). Increasing numbers of antivirals have been approved to facilitate" exact="influenza" post="treatment. Amantadine and rimantadine target the IAV M2 proteins,"/>
  <result pre="been shown in the literature to possess various functions during" exact="influenza" post="virus infection. ANXA1, ANXA2, ANXA5, and ANXA6 amongst others"/>
  <result pre="during IAV infection is essential to develop therapeutics targeting the" exact="viral disease." post="One of the earliest reports to implicate FPR2 in"/>
  <result pre="reported that the binding of ANXA2 to highly pathogenic H5N1" exact="influenza" post="virus non-structural protein 1 (NS1) enhances viral replication (Ma"/>
  <result pre="a 33 kDa protein that binds 3 different strains of" exact="influenza" post="A and one strain of influenza B via a"/>
  <result pre="3 different strains of influenza A and one strain of" exact="influenza" post="B via a sialic acid-independent mechanism (Otto et al.,"/>
  <result pre="(Otto et al., 1994). It was further shown that ANXA5" exact="aids" post="the entry of influenza viruses into cells, by acting"/>
  <result pre="It was further shown that ANXA5 aids the entry of" exact="influenza" post="viruses into cells, by acting as an alternative receptor"/>
  <result pre="The first evidence on the possible role of ANXA6 in" exact="influenza" post="virus infection was its ability to interact with the"/>
  <result pre="AriasC. F.Escalera-ZamudioM.Soto-Del Rio MdeL. A.Cobian-GuemesG.IsaP.LopezS. (2009). Molecular anatomy of 2009" exact="influenza" post="virus A (H1N1).Arch. Med. Res.40643–654. 10.1016/j.arcmed.2009.10.00720304251 AroraS.LimW.BistP.PerumalsamyR.LukmanH. M.LiF.et al."/>
  <result pre="Chem.28724690–24697. 10.1074/jbc.M112.37710122610094 BerriF.HaffarG.LeV. B.SadewasserA.PakiK.LinaB.et al. (2014). Annexin V incorporated into" exact="influenza" post="virus particles inhibits gamma interferon signaling and promotes viral"/>
  <result pre="RIP1 to constitutively activate IKK complex and NF-kappaB: implication in" exact="breast cancer" post="metastasis.Oncogene303174–3185. 10.1038/onc.2011.2821383699 BistP.ShuS.LeeH.AroraS.NairS.LimJ. Y.et al. (2013). Annexin-A1 regulates TLR-mediated"/>
  <result pre="to constitutively activate IKK complex and NF-kappaB: implication in breast" exact="cancer" post="metastasis.Oncogene303174–3185. 10.1038/onc.2011.2821383699 BistP.ShuS.LeeH.AroraS.NairS.LimJ. Y.et al. (2013). Annexin-A1 regulates TLR-mediated"/>
  <result pre="J. Pharmacol.1027–9. 10.1111/j.1476-5381.1991.tb12122.x1828384 De ClercqE. (2006). Antiviral agents active against" exact="influenza" post="A viruses.Nat. Rev. Drug Discov.51015–1025. 10.1038/nrd217517139286 de GraauwM.van MiltenburgM."/>
  <result pre="A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like" exact="breast cancer" post="cells.Proc. Natl. Acad. Sci. U.S.A.1076340–6345. 10.1073/pnas.091336010720308542 DuftonN.HannonR.BrancaleoneV.DalliJ.PatelH. B.GrayM.et al."/>
  <result pre="regulates TGF-beta signaling and promotes metastasis formation of basal-like breast" exact="cancer" post="cells.Proc. Natl. Acad. Sci. U.S.A.1076340–6345. 10.1073/pnas.091336010720308542 DuftonN.HannonR.BrancaleoneV.DalliJ.PatelH. B.GrayM.et al."/>
  <result pre="Natl. Acad. Sci. U.S.A.11018033–18034. 10.1073/pnas.131779811024154723 FukuyamaS.KawaokaY. (2011). The pathogenesis of" exact="influenza" post="virus infections: the contributions of virus and host factors.Curr."/>
  <result pre="T.LichtenbergB.RickO. (1996). Involvement of annexin V in the entry of" exact="influenza" post="viruses and role of phospholipids in infection.FEBS Lett.39259–62. 10.1016/0014-5793(96)00783-18769315"/>
  <result pre="accumulation is a host cell-protective mechanism inhibiting endosomal escape of" exact="influenza" post="a virus.mBio9:e1345-18. 10.1128/mBio.01345-1830042202 LeBouderF.MorelloE.RimmelzwaanG. F.BosseF.PechouxC.DelmasB. (2008). Annexin II incorporated"/>
  <result pre="a virus.mBio9:e1345-18. 10.1128/mBio.01345-1830042202 LeBouderF.MorelloE.RimmelzwaanG. F.BosseF.PechouxC.DelmasB. (2008). Annexin II incorporated into" exact="influenza" post="virus particles supports virus replication by converting plasminogen into"/>
  <result pre="Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in" exact="influenza" post="virions.Nat. Commun.5:5645. 10.1038/ncomms664525487526 LimL. H.PervaizS. (2007). Annexin 1: the"/>
  <result pre="10.1073/pnas.95.24.145359826735 MaH.KienF.ManiereM.ZhangY.LagardeN.TseK. S.et al. (2012). Human annexin A6 interacts with" exact="influenza" post="a virus protein M2 and negatively modulates infection.J. Virol.861789–1801."/>
  <result pre="protein 1 and promotes the replication of highly pathogenic H5N1" exact="avian influenza" post="virus.BMC Microbiol.17:191. 10.1186/s12866-017-1097-028893180 MadernaP.CottellD. C.ToivonenT.DuftonN.DalliJ.PerrettiM. (2010). FPR2/ALX receptor expression"/>
  <result pre="1 and promotes the replication of highly pathogenic H5N1 avian" exact="influenza" post="virus.BMC Microbiol.17:191. 10.1186/s12866-017-1097-028893180 MadernaP.CottellD. C.ToivonenT.DuftonN.DalliJ.PerrettiM. (2010). FPR2/ALX receptor expression"/>
  <result pre="10.1186/s12967-016-0843-727071553 MoraesL. A.KarS.FooS. L.GuT.TohY. Q.AmpomahP. B.et al. (2017). Annexin-A1 enhances" exact="breast cancer" post="growth and migration by promoting alternative macrophage polarization in"/>
  <result pre="MoraesL. A.KarS.FooS. L.GuT.TohY. Q.AmpomahP. B.et al. (2017). Annexin-A1 enhances breast" exact="cancer" post="growth and migration by promoting alternative macrophage polarization in"/>
  <result pre="MüllerK. H.KakkolaL.NagarajA. S.CheltsovA. V.AnastasinaM.KainovD. E. (2012). Emerging cellular targets for" exact="influenza" post="antiviral agents.Trends Pharmacol. Sci.3389–99. 10.1016/j.tips.2011.10.00422196854 MuramotoY.NodaT.KawakamiE.AkkinaR.KawaokaY. (2013). Identification of"/>
  <result pre="antiviral agents.Trends Pharmacol. Sci.3389–99. 10.1016/j.tips.2011.10.00422196854 MuramotoY.NodaT.KawakamiE.AkkinaR.KawaokaY. (2013). Identification of novel" exact="influenza" post="A virus proteins translated from PA mRNA.J. Virol.872455–2462. 10.1128/JVI.02656-1223236060"/>
  <result pre="Virol.872455–2462. 10.1128/JVI.02656-1223236060 MusiolA.GranS.EhrhardtC.LudwigS.GrewalT.GerkeV. (2013). Annexin A6-balanced late endosomal cholesterol controls" exact="influenza" post="A replication and propagation.mBio4:e00608-13. 10.1128/mBio.00608-1324194536 NicholsonK. G.WoodJ. M.ZambonM. (2003)."/>
  <result pre="33 kDa in cultured cells as a binding protein of" exact="influenza" post="viruses.FEBS Lett.356125–129. 10.1016/0014-5793(94)01241-57988705 PepinskyR. B.SinclairL. K. (1986). Epidermal growth"/>
  <result pre="Pharmacol.501037–1042. 10.1016/0006-2952(95)00238-U7575659 PetrovaV. N.RussellC. A. (2018). The evolution of seasonal" exact="influenza" post="viruses.Nat. Rev. Microbiol.1647–60. 10.1038/nrmicro.2017.14629081496 PleschkaS.WolffT.EhrhardtC.HobomG.PlanzO.RappU. R. (2001). Influenza virus"/>
  <result pre="The Annexin A1 receptor FPR2 regulates the endosomal export of" exact="influenza" post="virus.Int. J. Mol. Sci.19:E1400. 10.3390/ijms1905140029738458 RescherU.GerkeV. (2004). Annexins–unique membrane"/>
  <result pre="10.1038/nature1347924899309 ShawM. L.StoneK. L.ColangeloC. M.GulcicekE. E.PaleseP. (2008). Cellular proteins in" exact="influenza" post="virus particles.PLoS Pathog.4:e1000085. 10.1371/journal.ppat.100008518535660 ShenZ.LouK.WangW. (2015). New small-molecule drug"/>
  <result pre="ShenZ.LouK.WangW. (2015). New small-molecule drug design strategies for fighting resistant" exact="influenza" post="A.Acta Pharm. Sin. B5419–430. 10.1016/j.apsb.2015.07.00626579472 ShiY.WuY.ZhangW.QiJ.GaoG. F. (2014). Enabling"/>
  <result pre="Enabling the ‘host jump’: structural determinants of receptor-binding specificity in" exact="influenza" post="A viruses.Nat. Rev. Microbiol.12822–831. 10.1038/nrmicro336225383601 SolitoE.ChristianH. C.FestaM.MullaA.TierneyT.FlowerR. J.et al."/>
  <result pre="Immunol. Res.20168239258. 10.1155/2016/823925826885535 TaubenbergerJ. K.MorensD. M. (2008). The pathology of" exact="influenza" post="virus infections.Annu. Rev. Pathol.3499–522. 10.1146/annurev.pathmechdis.3.121806.15431618039138 TcherniukS.CenacN.ComteM.FrouardJ.Errazuriz-cerdaE.GalabovA.et al. (2016). Formyl"/>
  <result pre="Rep.6:27028. 10.1038/srep2702827426034 ZhirnovO. P.KlenkH. D. (2007). Control of apoptosis in" exact="influenza" post="virus-infected cells by up-regulation of Akt and p53 signaling.Apoptosis121419–1432."/>
 </snippets>
</snippetsTree>
